VSL # 3
Natural health product licensed in Canada
- Licence holder
- Actial Farmaceutica Srl
- NPN or DIN-HM
- 80037590
- Status
- Active licence
- Licence date
- 19 November 2012
- Revision date
- 11 February 2020
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Streptococcus thermophilus Source : SD-5207 | Not specified | Not calculated |
| Streptococcus thermophilus Source : Cellule entière | Not specified | Not calculated |
| Bifidobacterium breve Source : SD-5206 | Not specified | Not calculated |
| Bifidobacterium breve Source : Cellule entière | Not specified | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | Not specified | Not calculated |
| Lactobacillus acidophilus Source : SD-5212 | Not specified | Not calculated |
| Lactobacillus delbrueckii subsp. bulgaricus Source : SD-5210 | Not specified | Not calculated |
| Lactobacillus delbrueckii subsp. bulgaricus Source : Cellule entière | Not specified | Not calculated |
Non-medicinal ingredients
Maltodextrine, alpha-D-Glucopyranosyle-alpha-D-glucopyranoside, Sodium aspartate, Sucrose, Maltose, Sulfate de magnésium, Saveur, Monopotassium phosphate, Hydrogénophosphate de dipotassium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 sachet | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps maintain the appropriate balance of beneficial bacteria in the bowel of pouchitis patients. VSL # 3 is used to reduce the risk of relapse in pouchitis patients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80037590
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.